New cardiac devices fail to impress cardiologists in major US study
This article was originally published in Clinica
New catheter-based devices to open clogged arteries are no better than conventional balloons, a major US study has concluded. With the exception of stents, the study casts doubt on many of the recent innovations including lasers and atherectomy devices.
You may also be interested in...
Celltrion has accelerated the development of its antiviral treatment for COVID-19 and aims to launch a rapid self-testing kit that could provide results within 15-20 minutes. The Korean firm also plans to develop a ‘super antibody’ to prepare for potential future pandemic situations.
Paracetamol, acetylcysteine and loperamide among list of OTC drugs deemed "essential" by Spain in the fight against coronavirus.
Mylan, in partnership with Indian firm Lupin, will be looking to rival Biogen and Sandoz by introducing an etanercept biosimilar in European markets following a positive opinion by the EMA’s CHMP on Mylan's application.